Skip Navigation

European Heart Journal 2003 24(20):1898; doi:10.1016/j.ehj.2003.06.006
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thimme, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thimme, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

A critical amendment to the Meta-analysis of clinical trials comparing Thrombolysis with Primary Angioplasty

Michael Thimme*

Aventis Behring GmbH Germany, Business Unit Critical Care, Emil-v.- Behring Str., 35037 Marburg, Hessen, Germany

* Corresponding author. Tel.: +49-6421-39-4130; fax: +49-6421-39-4146
E-mail address: michael.thimme@aventis.com

Received 13 May 2003; accepted 20 June 2003

The first 10% of the full text of this article appears below.

I refer to the publication of Zijlstra,1who compares two therapeutic concepts in the treatment of acute myocardial infarction. The author concluded that this study demonstrates the advantage of primary angioplasty vs thrombolysis. The analysis mainly focuses on outcome parameters, which of course are of utmost importance, but . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?